Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease

Alon Eisen1, Michal Benderly2, Solomon Behar3

  • 1Cardiology Department, Rabin Medical Center, Petah-Tikva, Israel.

American Heart Journal
|April 29, 2014
PubMed

Insights

Elevated inflammatory markers like C-reactive protein (CRP), fibrinogen, and white blood cells (WBCs) are linked to a higher risk of heart failure (HF) in coronary artery disease (CAD) patients. Myocardial infarction partially mediates this association.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Public Health

Background:

  • Heart failure (HF) poses a significant risk for patients with coronary artery disease (CAD).
  • Inflammation is a known predictor of cardiovascular events in CAD patients.
  • The association between inflammatory markers and incident HF in this population remains unclear.

Purpose of the Study:

  • To investigate the link between inflammatory markers and the risk of developing HF in stable CAD patients.
  • To explore the potential mediating role of myocardial infarction (MI) in this relationship.

Main Methods:

  • Analysis of 2,945 patients with stable CAD, free of HF at baseline.
  • Median follow-up duration of 7.9 years.
  • Assessment of baseline inflammatory markers including C-reactive protein (CRP), fibrinogen, and white blood cells (WBCs).

Main Results:

  • 17.2% of patients developed HF during follow-up.
  • Higher baseline levels of CRP, fibrinogen, and WBCs were observed in patients who developed HF.
  • Elevated inflammatory markers showed a dose-response relationship with incident HF, with hazard ratios ranging from 1.33 to 1.38 for the third tertiles.
  • A combined inflammation score indicated a higher HF risk (HR 1.83 for the fifth quintile).
  • Myocardial infarction partially mediated the association between inflammatory markers and subsequent HF.

Conclusions:

  • Increased levels of CRP, fibrinogen, and WBCs are independently associated with a higher incidence of HF in patients with stable CAD.
  • These findings highlight the prognostic value of inflammatory markers in predicting HF risk in this patient group.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K